🇺🇸 FDA
Patent

US 10221174

N-(phenylsulfonyl)benzamides and related compounds as BCL-2 inhibitors

granted A61PA61P35/00A61P35/02

Quick answer

US patent 10221174 (N-(phenylsulfonyl)benzamides and related compounds as BCL-2 inhibitors) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00, A61P35/02